Cure My Disease

Don't miss your cure!

 Log in / Sign up

Free meds and tailored education may cut heart risks in Low-Income seniors

NCT ID NCT02579655

Disease control Sponsor: University of Calgary Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests two strategies in low-income seniors with chronic conditions like heart disease, diabetes, or kidney disease. One group gets free preventive medications (no copayment), and another receives personalized education on medication use and lifestyle. The goal is to see if these measures reduce deaths, heart attacks, strokes, and hospitalizations over three years.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Copayment elimination and personalized education
What this could lead to
If it works, this approach could lower the risk of heart attacks, strokes, and hospitalizations in low-income seniors with chronic diseases.
What could go wrong
The study focuses on a specific group (low-income seniors in Alberta), so results may not apply to others. The interventions are behavioral and policy-based, so effects may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

4,764 people

The number who actually took part.

Started

Nov 2015

Finished

Jun 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \>65 years of age (have drug insurance from Alberta Blue Cross with 30% copayment) Have any one of the following: * coronary disease * prior stroke * chronic kidney disease * heart failure OR any two of the following: * current cigarette smoking (\>1/2 pack per day) * diabetes mellitus * hypertension * hypercholesterolemia Have total family income \<$50,000 Exclusion Criteria: * Coverage by another insurance plan where no drug payment is required (i.e. copayment \<30%) * Inability to participate in education modules (e.g. lack of proficiency in English; cognitive impairment). * Has every dose of their medication provided to them by a nurse or other professional caregiver? * Inability to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome coronary artery disorder Coronary Disease diabetes mellitus heart failure Hypercholesterolemia hyperlipidemia hypertensive disorder stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease Coronary disease Diabetes mellitus Heart failure Hypercholesterolemia Hypertension Stroke

Contacts and locations

Locations

  • University of Calgary

    Calgary, Alberta, T2N 4Z6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.